{"id":54923,"date":"2023-03-16T18:03:09","date_gmt":"2023-03-16T17:03:09","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/"},"modified":"2023-03-16T18:03:09","modified_gmt":"2023-03-16T17:03:09","slug":"transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/","title":{"rendered":"Transcarent Announces Randy K. Hawkins, M.D. as Chief Medical Officer"},"content":{"rendered":"
\n

\nDr. Hawkins, an anesthesiologist, healthcare executive and Navy veteran, to lead Transcarent\u2019s quality and analytics initiatives<\/i>\n<\/p>\n

PALO ALTO, Calif.–(BUSINESS WIRE)–#behavioralhealth<\/a>—Transcarent<\/a>, a health and care experience company that makes it easy for people to access high-quality, affordable care announced today that Dr. Randy Hawkins has joined the organization as Chief Medical Officer. Reporting to Transcarent Chief Executive Officer, Glen Tullman, Dr. Hawkins will oversee the organization\u2019s clinical quality initiatives and support the organization\u2019s health analytics strategy.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nDr. Hawkins brings more than 30 years of experience in the healthcare industry including patient care delivery, and military medicine in addition to healthcare consulting and management. Dr. Hawkins joins Transcarent from Carrum where he was the Chief Medical Officer. Previously, he served as Chief Medical Officer and EVP, Health Analytics at ConsumerMedical and he has also served in other senior clinical roles over his career at Connance, Glytec, and PatientKeeper, where he focused on patient safety and interoperability as their Chief Medical Information Officer.\n<\/p>\n

\n\u201cDr. Hawkins understands that in order to deliver high-quality, affordable care at scale, we need to use a blend of technology and analytics to create a new kind of health and care experience for our Members and the physicians who serve them,\u201d said Tullman. \u201cHis expertise is a perfect fit to serve as Transcarent\u2019s most senior clinical leader.\u201d\n<\/p>\n

\nDr. Hawkins served as a Medical Officer in the U.S. Navy and is a decorated combat veteran of Operations Desert Shield and Desert Storm. He was also an anesthesiologist in private practice for more than 12 years.\n<\/p>\n

\n\u201cWe have made remarkable progress in enhancing care at the bedside by giving clinicians cutting-edge technologies and integrating innovation into the provision of care, but the industry has yet to empower patients in a meaningful way so they can make their own healthcare decisions with confidence. All health consumers deserve access to the information and support they need, access to providers, and an unwavering commitment to quality throughout their health and care journey,\u201d said Hawkins. \u201cTranscarent is bringing a solution to health consumers and clinicians that is different from anything I\u2019ve seen in unique and important ways.\u201d\n<\/p>\n

\nDr. Hawkins attended Dartmouth College, Georgetown University School of Medicine, and completed his residency training in anesthesiology at the University of Florida College of Medicine.\n<\/p>\n

\nAbout Transcarent<\/b>\n<\/p>\n

\nTranscarent is a health and care experience company that makes it easy for people to access high-quality, affordable care. Through an integrated mobile or web platform, Members can access EveryDay Care, for example, chat with a provider in less than 60 seconds, Pharmacy Care, Care@Home (or close to it), Surgery Care, or receive additional support for complex care needs like cancer and behavioral health.\n<\/p>\n

\nTranscarent takes accountability for results \u2013 offering at-risk pricing models and transparent impact reporting to align incentives towards a measurably better experience, better health, and lower costs. For more Information, visit www.transcarent.com<\/a> and follow on Twitter<\/a> or LinkedIn<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:
\n
Leslie Krigstein
\n
802-598-3305
\n
Press@transcarent.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Dr. Hawkins, an anesthesiologist, healthcare executive and Navy veteran, to lead Transcarent\u2019s quality and analytics initiatives PALO ALTO, Calif.–(BUSINESS WIRE)–#behavioralhealth—Transcarent, a health and care experience company that makes it easy for people to access high-quality, affordable care announced today that Dr. Randy Hawkins has joined the organization as Chief Medical Officer. Reporting to Transcarent Chief … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54923","6":"format-standard","7":"category-industry"},"yoast_head":"\nTranscarent Announces Randy K. Hawkins, M.D. as Chief Medical Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Transcarent Announces Randy K. Hawkins, M.D. as Chief Medical Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Dr. Hawkins, an anesthesiologist, healthcare executive and Navy veteran, to lead Transcarent\u2019s quality and analytics initiatives PALO ALTO, Calif.–(BUSINESS WIRE)–#behavioralhealth—Transcarent, a health and care experience company that makes it easy for people to access high-quality, affordable care announced today that Dr. Randy Hawkins has joined the organization as Chief Medical Officer. Reporting to Transcarent Chief ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-16T17:03:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230316005578\/en\/1740686\/21\/Randy_Hawkins_MD_New_Headshot_2023.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Transcarent Announces Randy K. Hawkins, M.D. as Chief Medical Officer\",\"datePublished\":\"2023-03-16T17:03:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\\\/\"},\"wordCount\":511,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230316005578\\\/en\\\/1740686\\\/21\\\/Randy_Hawkins_MD_New_Headshot_2023.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\\\/\",\"name\":\"Transcarent Announces Randy K. Hawkins, M.D. as Chief Medical Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230316005578\\\/en\\\/1740686\\\/21\\\/Randy_Hawkins_MD_New_Headshot_2023.jpg\",\"datePublished\":\"2023-03-16T17:03:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230316005578\\\/en\\\/1740686\\\/21\\\/Randy_Hawkins_MD_New_Headshot_2023.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230316005578\\\/en\\\/1740686\\\/21\\\/Randy_Hawkins_MD_New_Headshot_2023.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transcarent Announces Randy K. Hawkins, M.D. as Chief Medical Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Transcarent Announces Randy K. Hawkins, M.D. as Chief Medical Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/","og_locale":"en_US","og_type":"article","og_title":"Transcarent Announces Randy K. Hawkins, M.D. as Chief Medical Officer - Pharma Trend","og_description":"Dr. Hawkins, an anesthesiologist, healthcare executive and Navy veteran, to lead Transcarent\u2019s quality and analytics initiatives PALO ALTO, Calif.–(BUSINESS WIRE)–#behavioralhealth—Transcarent, a health and care experience company that makes it easy for people to access high-quality, affordable care announced today that Dr. Randy Hawkins has joined the organization as Chief Medical Officer. Reporting to Transcarent Chief ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-16T17:03:09+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230316005578\/en\/1740686\/21\/Randy_Hawkins_MD_New_Headshot_2023.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Transcarent Announces Randy K. Hawkins, M.D. as Chief Medical Officer","datePublished":"2023-03-16T17:03:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/"},"wordCount":511,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230316005578\/en\/1740686\/21\/Randy_Hawkins_MD_New_Headshot_2023.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/","url":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/","name":"Transcarent Announces Randy K. Hawkins, M.D. as Chief Medical Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230316005578\/en\/1740686\/21\/Randy_Hawkins_MD_New_Headshot_2023.jpg","datePublished":"2023-03-16T17:03:09+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230316005578\/en\/1740686\/21\/Randy_Hawkins_MD_New_Headshot_2023.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230316005578\/en\/1740686\/21\/Randy_Hawkins_MD_New_Headshot_2023.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/transcarent-announces-randy-k-hawkins-m-d-as-chief-medical-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Transcarent Announces Randy K. Hawkins, M.D. as Chief Medical Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54923","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54923"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54923\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}